What is the ticker symbol for Viridian Therapeutics, Inc.?

The ticker symbol for Viridian Therapeutics, Inc. is NASDAQ:VRDN

Does Viridian Therapeutics, Inc. pay dividends?

No, Viridian Therapeutics, Inc. does not pay dividends

What sector is Viridian Therapeutics, Inc. in?

Viridian Therapeutics, Inc. is in the Healthcare sector

What industry is Viridian Therapeutics, Inc. in?

Viridian Therapeutics, Inc. is in the Biotechnology industry

What country is Viridian Therapeutics, Inc. based in?

Viridian Therapeutics, Inc. is headquartered in United States

When did Viridian Therapeutics, Inc. go public?

Viridian Therapeutics, Inc. initial public offering (IPO) was on June 18, 2014

Is Viridian Therapeutics, Inc. in the S&P 500?

No, Viridian Therapeutics, Inc. is not included in the S&P 500 index

Is Viridian Therapeutics, Inc. in the NASDAQ 100?

No, Viridian Therapeutics, Inc. is not included in the NASDAQ 100 index

Is Viridian Therapeutics, Inc. in the Dow Jones?

No, Viridian Therapeutics, Inc. is not included in the Dow Jones index

When was Viridian Therapeutics, Inc. last earnings report?

Viridian Therapeutics, Inc.'s most recent earnings report was on August 6, 2026

When does Viridian Therapeutics, Inc. report earnings?

The next expected earnings date for Viridian Therapeutics, Inc. is November 5, 2026

VRDN Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, VRDN price is $23.45, up +2.31% in the most recent trading session on September 8, 2026
Current Price All-Time High: VRDN price is currently -98.96% below its historical high of $2,247.75 set on June 18, 2014
Market Cap: VRDN current market cap is $3B, up +64.25% over the past 365 days
Revenue: VRDN current annual revenue is $70.85M, up +23359.93% year-over-year
Next Earnings: The next earnings release for VRDN is on November 5, 2026

Profile

Company profile for Viridian Therapeutics, Inc. (VRDN)
Metric	Value
Full Name	Viridian Therapeutics, Inc.
Ticker	NASDAQ: VRDN
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Jun 18, 2014
Indexes	Not included
Website	viridiantherapeutics.com
Employees	143

Key Metrics

Viridian Therapeutics, Inc. Key Details
Metric	Value	Date
Price	$23.45	Sep 8, 26
Price, 1D Change	+2.31%	Sep 8, 26
	$3B	Sep 8, 26
	-	Sep 8, 26
	-	Sep 8, 26
	1.07	Sep 4, 26
	$70.85M	Dec 31, 25
Revenue, 1Y Change	+23,359.93%	Dec 31, 25
	-$3.32	Dec 31, 25
EPS, 1Y Change	-8.21%	Dec 31, 25

Events

Viridian Therapeutics, Inc. Events
Metric	Value	Date
Next Earnings		Nov 5, 26
Last Qtr. Earnings		Aug 6, 26
Last Ann. Earnings		Feb 26, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	1:15	Nov 13, 20
Next Split	N/A	N/A
Last Ticker Change	MGEN	Jan 20, 21
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

VRDN Estimates
Metric	Value	Date
	-$3.32	Dec 31, 25
EPS Estimate	-$3.95	N/A
EPS Est. Change	-18.78%	N/A
	$70.85M	Dec 31, 25
Revenue Estimate	$27.92M	N/A
Revenue Est. Change	-60.59%	N/A
Current Price	$23.45	Sep 8, 26
Price Target	$35.50	-
Price Tgt. Change	+51.39%	-

🔒 Log In To Unlock Full Data

EPS

VRDN EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$3.99	-$3.07	+22.96%
2025	-$3.54	-$3.32	+5.96%
2026	-$3.95	N/A	-18.78%
2027	-$2.77	N/A	+16.59%

Revenue

VRDN revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$314.57K	$302.00K	-4.00%
2025	$86.48M	$70.85M	-18.07%
2026	$27.92M	N/A	-60.59%
2027	$231.55M	N/A	+226.83%

🔒 Log In To Unlock Full Data

Performance

VRDN Performance
Metric	Value	Date
Price, 1Y	+18.37%	Sep 8, 26
Price, 3Y	+28.99%	Sep 8, 26
	+64.25%	Sep 8, 26
	+235.46%	Sep 8, 26
	+23,359.93%	Dec 31, 25
	+3,898.25%	Dec 31, 25
	-8.21%	Dec 31, 25
	+17.86%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

VRDN Technical Indicators
Metric	Value	Date
Current Price	$23.45	Sep 8, 26
	$23.78	Sep 4, 26
	$21.08	Sep 4, 26
	$21.34	Sep 4, 26
	$21.48	Sep 4, 26
	$0.59	Sep 4, 26
	1.07	Sep 4, 26
	$0.82	Sep 4, 26
	53.83	Sep 4, 26
	20.15%	Sep 4, 26

Dividends

VRDN Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Sep 8, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

VRDN Income & Profitability
Metric	Value	Date
	$70.85M	Dec 31, 25
	-$3.32	Dec 31, 25
	$69.69M	Dec 31, 25
	98.36%	Dec 31, 25
	-$363.40M	Dec 31, 25
	-512.91%	Dec 31, 25
	-$281.93M	Dec 31, 25
	-397.93%	Dec 31, 25
	-$362.24M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

VRDN Financial Health
Metric	Value	Date
	0.07	Dec 31, 25
	12.65	Dec 31, 25
	12.65	Dec 31, 25
	-	Dec 31, 25
	4	Jun 30, 26
	6.75	Sep 8, 26

Valuations

VRDN Valuations
Metric	Value	Date
	-	Sep 8, 26
	37.35	Sep 8, 26
	4.71	Sep 8, 26
	-4.74	Sep 8, 26
	-	N/A

Balance Sheet

VRDN Balance Sheet
Metric	Value	Date
	$590.11M	Dec 31, 25
	$874.65M	Dec 31, 25
	$899.42M	Dec 31, 25
	$894.23M	Dec 31, 25
	$177.25M	Dec 31, 25
	$70.70M	Dec 31, 25
	$50.69M	Dec 31, 25
	$753.00K	Dec 31, 25
	$8.68M	Dec 31, 25

Expenses

VRDN Expenses
Metric	Value	Date
	$352.78M	Dec 31, 25
	$433.08M	Dec 31, 25
	$1.16M	Dec 31, 25
	$95.32M	Dec 31, 25
	$460.00K	Dec 31, 25
	$0.00	Dec 31, 25
	$0.00	Dec 31, 25

Cash Flow

VRDN Cash Flow
Metric	Value	Date
	-$276.87M	Dec 31, 25
	-$37.56M	Dec 31, 25
	$427.22M	Dec 31, 25
	$495.00K	Dec 31, 25
	-$277.36M	Dec 31, 25

Recent analyst updates

VRDN Recent analyst updates
Metric	Value	Date
Truist Securities	→	Aug 7, 26
RBC Capital	→	Aug 7, 26
Wedbush	→	Jun 30, 26
Truist Securities	→	Jun 30, 26
RBC Capital	→	Jun 30, 26
Needham	→	Jun 30, 26
Wells Fargo	→	Jun 29, 26
Needham	→	Jun 29, 26
Evercore ISI Group	→	May 15, 26
RBC Capital	→	May 6, 26

Analyst sentiment

Institutional ownership

No data

Screeners with VRDN

FAQ

What is the ticker symbol for Viridian Therapeutics, Inc.?: The ticker symbol for Viridian Therapeutics, Inc. is NASDAQ:VRDN
Does Viridian Therapeutics, Inc. pay dividends?: No, Viridian Therapeutics, Inc. does not pay dividends
What sector is Viridian Therapeutics, Inc. in?: Viridian Therapeutics, Inc. is in the Healthcare sector
What industry is Viridian Therapeutics, Inc. in?: Viridian Therapeutics, Inc. is in the Biotechnology industry
What country is Viridian Therapeutics, Inc. based in?: Viridian Therapeutics, Inc. is headquartered in United States
When did Viridian Therapeutics, Inc. go public?: Viridian Therapeutics, Inc. initial public offering (IPO) was on June 18, 2014
Is Viridian Therapeutics, Inc. in the S&P 500?: No, Viridian Therapeutics, Inc. is not included in the S&P 500 index
Is Viridian Therapeutics, Inc. in the NASDAQ 100?: No, Viridian Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Viridian Therapeutics, Inc. in the Dow Jones?: No, Viridian Therapeutics, Inc. is not included in the Dow Jones index
When was Viridian Therapeutics, Inc. last earnings report?: Viridian Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
When does Viridian Therapeutics, Inc. report earnings?: The next expected earnings date for Viridian Therapeutics, Inc. is November 5, 2026

Data Sources & References

VRDN Official Website www.viridiantherapeutics.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590750/000159075026000007/0001590750-26-000007-index.htm
VRDN Profile on Yahoo Finance finance.yahoo.com/quote/VRDN
VRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrdn